Isolation and transplantation of highly purified autologous peripheral CD34+ progenitor cells: purging efficacy, hematopoietic reconstitution and long-term outcome in children with high-risk neuroblastoma
- 1 May 2002
- journal article
- clinical trial
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 29 (9) , 731-736
- https://doi.org/10.1038/sj.bmt.1703536
Abstract
Bone Marrow Transplantation is a high quality, peer-reviewed journal covering all aspects of clinical and basic haemopoietic stem cell transplantation.Keywords
This publication has 28 references indexed in Scilit:
- NeuroblastomaDrugs, 2000
- Clinical scale isolation of highly purified peripheral CD34+progenitors for autologous and allogeneic transplantation in childrenBone Marrow Transplantation, 1999
- Isolation of Highly Purified Autologous and Allogeneic Peripheral CD34+ Cells Using the CliniMACS DeviceJournal of Hematotherapy, 1999
- Frequent detection of tumor cells in hematopoietic grafts in neuroblastoma and Ewing’s sarcomaBone Marrow Transplantation, 1998
- Isolation and transplantation of autologous peripheral CD34+ progenitor cells highly purified by magnetic-activated cell sortingBone Marrow Transplantation, 1998
- Positive Selection and Transplantation of Peripheral CD34+ Progenitor Cells: Feasibility and Purging Efficacy in Pediatric Patients with NeuroblastomaJournal of Hematotherapy, 1997
- The ISHAGE Guidelines for CD34+ Cell Determination by Flow CytometryJournal of Hematotherapy, 1996
- Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cellsBlood, 1994
- Gene-marking to trace origin of relapse after autologous bone-marrow transplantationThe Lancet, 1993
- High-dose melphalan with autologous marrow for treatment of advanced neuroblastomaBritish Journal of Cancer, 1982